N1X10

Personalized Oncology Advocacy

Health Tech & Life Sciences
Non Active, Jan 2026 ceased to operate
Pre-Funding Tel Aviv-Yafo, Israel Founded 2019
LinkedIn
Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2019
Headcount
16
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

N1X10 offers a personalized oncology advocacy service that educates and empowers cancer patients to overcome the limitations of standard care. Using its proprietary technology and methodology, N1X10 connects patients to a global market network of cancer professionals.

Q&A

What is N1X10's primary business?
N1X10 offers a personalized oncology advocacy service that educates and empowers cancer patients to overcome the limitations of standard care, connecting them to a global network of cancer professionals using proprietary technology.
When was N1X10 founded?
N1X10 was founded in August 2019.
What is the current operational status of N1X10?
N1X10 is currently inactive, having ceased to operate in January 2026.
Where is N1X10 headquartered?
N1X10 is headquartered in Tel Aviv-Yafo, Israel.
How many employees does N1X10 have?
N1X10 has an employee count in the 11-50 range.
Who is a key founder of N1X10?
Ran Goshen is a founder, Chairman, and CMO of N1X10.
What is N1X10's primary sector classification?
N1X10's primary sector classification is Health Tech & Life Sciences.
What business models does N1X10 utilize?
N1X10 utilizes B2B2C, B2C, and B2B business models.

Team · 1

Ran Goshen
Founder · Founder, Chairman & CMO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareClinical Workflow
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B2CB2CB2B

Highlights

Verified
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)